Kingfisher Biotech

Description

• Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species. Our primary focus is to develop quality reagents for use in species previously under-served (bovine, canine, chicken, equine, feline, swine, and turkey). We have also added reagents for dolphin, guinea pig, mouse, and rat. We will continue to add species as our customer request specific reagents for their research. Currently, we offer over 500 reagents and kits for veterinary and animal model research. If there is a product that you are looking for and can't find, please send us an email (info@kingfisherbiotech.com).APRIL (TNFSF13), BAFF (TNFSF13B), CCL2 (MCP-1), CCL3 (MIP-1 alpha), CCL3L1, CCL4 (MIP-1 beta), CCL5 (RANTES), CCL11 (Eotaxin), CCL20, CXCL1 (GRO alpha), CXCL9 (MIG), CXCL10 (IP-10), CXCL11 (I-TAC), CXCL12, FGF basic, GM-CSF, IFN alpha, IFN beta, IFN gamma, IGF-1, IGF-2, IL-1 alpha, IL-1 beta, IL-1F5, IL-1 receptor antagonist, IL-2, IL-4, IL-5, IL-6, IL-8 (CXCL8), IL-10, IL-12 p40, IL-13, IL-15, IL-16,IL-17A, IL-17F, IL-18, IL-21, IL-22, IL-23A, IL-24, M-CSF, MIF, RANKL (TNFSF11), SCF,TNF alpha, TNFSF15 (TL1A), TWEAK, VEGF-A
• 

  Headquarters:1000 Westgate Drive Suite 123, Saint Paul, Minnesota, United States

  More
• 

  Phone Number: +1 651-646-0089

• 

  Website: https://www.kingfisherbiotech.com

• 

  Employees:7

• 

  Revenue:$1 - 10M

• 

  Legal Name:Kingfisher Biotech

• Kingfisher Biotech's Social Media

  
• Is this data correct?

• |  NAICS Code: 541715  |

  Show More